3/6
01:34 pm
rhhby
Roche and Zealand's Phase II obesity trial divides analyst opinion [Yahoo! Finance]
Low
Report
Roche and Zealand's Phase II obesity trial divides analyst opinion [Yahoo! Finance]
3/6
08:58 am
rhhby
New England Journal of Medicine Publishes Phase III ALLEGORY Data Showing Genentech's Gazyva Significantly Reduces Disease Activity in the Most Common Form of Lupus [Yahoo! Finance]
Low
Report
New England Journal of Medicine Publishes Phase III ALLEGORY Data Showing Genentech's Gazyva Significantly Reduces Disease Activity in the Most Common Form of Lupus [Yahoo! Finance]
3/6
08:45 am
rhhby
New England Journal of Medicine Publishes Phase III ALLEGORY Data Showing Genentech’s Gazyva Significantly Reduces Disease Activity in the Most Common Form of Lupus
Low
Report
New England Journal of Medicine Publishes Phase III ALLEGORY Data Showing Genentech’s Gazyva Significantly Reduces Disease Activity in the Most Common Form of Lupus
3/5
04:35 pm
rhhby
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
Low
Report
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
3/5
01:55 pm
rhhby
Genentech Announces Positive Phase II Results for Petrelintide, an Amylin Analog Developed for People Living With Overweight and Obesity [Yahoo! Finance]
Low
Report
Genentech Announces Positive Phase II Results for Petrelintide, an Amylin Analog Developed for People Living With Overweight and Obesity [Yahoo! Finance]
3/5
01:45 pm
rhhby
Genentech Announces Positive Phase II Results for Petrelintide, an Amylin Analog Developed for People Living With Overweight and Obesity
Medium
Report
Genentech Announces Positive Phase II Results for Petrelintide, an Amylin Analog Developed for People Living With Overweight and Obesity
3/5
09:38 am
rhhby
Is Roche Holding (SWX:ROG) Still Attractively Priced After Strong Three Year Share Gains? [Yahoo! Finance]
Medium
Report
Is Roche Holding (SWX:ROG) Still Attractively Priced After Strong Three Year Share Gains? [Yahoo! Finance]
3/4
12:28 pm
rhhby
Roche announces $481m investment in South Korean biotech sector [Yahoo! Finance]
Low
Report
Roche announces $481m investment in South Korean biotech sector [Yahoo! Finance]
3/3
08:18 am
rhhby
Roche's Fenebrutinib MS Results Test Valuation And Growth Expectations [Yahoo! Finance]
Low
Report
Roche's Fenebrutinib MS Results Test Valuation And Growth Expectations [Yahoo! Finance]
3/2
01:30 am
rhhby
Genentech's Fenebrutinib Confirms Its Potential as First and Only BTK Inhibitor for Relapsing and Primary Progressive MS in Third Positive Phase III Study (FENhance 1) [Yahoo! Finance]
Low
Report
Genentech's Fenebrutinib Confirms Its Potential as First and Only BTK Inhibitor for Relapsing and Primary Progressive MS in Third Positive Phase III Study (FENhance 1) [Yahoo! Finance]
3/2
01:10 am
rhhby
Genentech's Fenebrutinib Confirms Its Potential as First and Only BTK Inhibitor for Relapsing and Primary Progressive MS in Third Positive Phase III Study (FENhance 1)
Low
Report
Genentech's Fenebrutinib Confirms Its Potential as First and Only BTK Inhibitor for Relapsing and Primary Progressive MS in Third Positive Phase III Study (FENhance 1)
2/26
06:01 pm
rhhby
Roche (RHHBY) had its "outperform" rating reaffirmed by Wolfe Research.
Low
Report
Roche (RHHBY) had its "outperform" rating reaffirmed by Wolfe Research.
2/25
04:14 pm
rhhby
Nykode Therapeutics AS (VACBF) Q4 2025 Earnings Call Highlights: Navigating Financial ... [Yahoo! Finance]
Low
Report
Nykode Therapeutics AS (VACBF) Q4 2025 Earnings Call Highlights: Navigating Financial ... [Yahoo! Finance]
2/25
01:39 pm
rhhby
Roche Holding (SWX:ROG) Valuation Check After Key FDA And Phase III Milestones [Yahoo! Finance]
Low
Report
Roche Holding (SWX:ROG) Valuation Check After Key FDA And Phase III Milestones [Yahoo! Finance]
2/25
08:23 am
rhhby
Parker Institute for Cancer Immunotherapy Announces Appointment of Bob Purcell as Chief Communications Officer [Yahoo! Finance]
Low
Report
Parker Institute for Cancer Immunotherapy Announces Appointment of Bob Purcell as Chief Communications Officer [Yahoo! Finance]
2/25
07:13 am
rhhby
BreezeBio banks $60M to make more precise genetic medicines [Yahoo! Finance]
Low
Report
BreezeBio banks $60M to make more precise genetic medicines [Yahoo! Finance]
2/23
05:00 pm
rhhby
Flatiron Health Attends the 2026 American Society of Genitourinary Cancers Symposium to Answer Oncology's Most Critical Questions
Low
Report
Flatiron Health Attends the 2026 American Society of Genitourinary Cancers Symposium to Answer Oncology's Most Critical Questions
2/20
02:00 am
rhhby
FDA Approves Genentech’s Venclexta® Plus Acalabrutinib Combination Regimen for Previously Untreated Chronic Lymphocytic Leukemia
Low
Report
FDA Approves Genentech’s Venclexta® Plus Acalabrutinib Combination Regimen for Previously Untreated Chronic Lymphocytic Leukemia
2/20
01:35 am
rhhby
FDA Accepts New Drug Application for Genentech's Giredestrant in ESR1-Mutated, ER-Positive Advanced Breast Cancer [Yahoo! Finance]
Low
Report
FDA Accepts New Drug Application for Genentech's Giredestrant in ESR1-Mutated, ER-Positive Advanced Breast Cancer [Yahoo! Finance]
2/20
01:25 am
rhhby
FDA accepts New Drug Application for Roche's giredestrant in ESR1-mutated, ER-positive advanced breast cancer [Yahoo! Finance]
Low
Report
FDA accepts New Drug Application for Roche's giredestrant in ESR1-mutated, ER-positive advanced breast cancer [Yahoo! Finance]
2/20
01:05 am
rhhby
FDA Accepts New Drug Application for Genentech’s Giredestrant in ESR1-Mutated, ER-Positive Advanced Breast Cancer
Low
Report
FDA Accepts New Drug Application for Genentech’s Giredestrant in ESR1-Mutated, ER-Positive Advanced Breast Cancer
2/18
09:00 am
rhhby
Flatiron Launches First-of-Its-Kind AI-Powered Global Prostate Cancer Datasets
Low
Report
Flatiron Launches First-of-Its-Kind AI-Powered Global Prostate Cancer Datasets
2/16
07:51 am
rhhby
Roche eyes Gazyva label expansion on positive Phase III kidney disease data [Yahoo! Finance]
Low
Report
Roche eyes Gazyva label expansion on positive Phase III kidney disease data [Yahoo! Finance]
2/16
01:00 am
rhhby
Genentech Announces Positive Phase III Results for Gazyva in Primary Membranous Nephropathy, Marking a Significant Milestone in This Autoimmune Disease
Low
Report
Genentech Announces Positive Phase III Results for Gazyva in Primary Membranous Nephropathy, Marking a Significant Milestone in This Autoimmune Disease
2/11
09:00 am
rhhby
Flatiron Health Names New Chief Business, Technology, and Product Leaders
Low
Report
Flatiron Health Names New Chief Business, Technology, and Product Leaders